Anthera Pharmaceuticals, Inc. (ANTH) said Friday that it has priced an underwritten public offering of about 60.6 million shares of its common stock, offered at a price of $0.66 per share.
The company estimates that the gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Anthera, will be $40.0 million.
In addition, the company has granted the underwriters a 30-day option to purchase up to an additional about 9.1 million shares of common stock.
The offering is expected to close on or about January 30.
The company plans to use the net proceeds from the offering for general corporate purposes.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.